Breaking Down Yunhong CTI Ltd. (CTIB) Financial Health: Key Insights for Investors

Investors scrutinizing Yunhong CTI Ltd. will find a mix of recovery and risk: in Q3 2025 revenue rose 16.3% year-over-year to $2.95 million, driven by foil balloons that made up 80% of sales (foil balloon revenue: $2.35 million), yet earlier in Q1 2025 revenue fell 1.9% to $4.80 million amid weaker helium pricing; profitability shows improvement-Q3 net loss narrowed 32% to $811,000 with EPS improving from a loss of $0.47 to $0.31 and gross margin at 2.27%-but valuation and market sentiment remain strained with a 33.7% stock plunge in October 2025 after a 1-for-10 reverse split and a P/E swinging to -26.67 in November 2025; balance-sheet and liquidity indicators flag concerns as total assets stood at $17.25 million against $13.51 million in liabilities (debt-to-assets ~78%), total debt reached $9.06 million (up 17.3% year-over-year), cash reserves dipped to $172,000 in Q1 2025 even as net cash improved to $390,000 in Q3 (a 7,640% YoY change), while accounts receivable climbed to $2.69 million and inventory rose to $8.7 million-yet strategic moves like the 2024 acquisition of biodegradable assets, investment in robotics, and a planned rebrand to Yunhong Green CTI (ticker 'YHGJ') point to growth avenues that merit a deeper read.

Yunhong CTI Ltd. (CTIB) Revenue Analysis

• Q3 2025 total revenue: $2.95M (+16.3% YoY)
• Q3 2025 foil balloon revenue: $2.35M (≈80% of total)
• Q3 2025 film products: $253,000
• Q3 2025 other segments: $348,000
• Q1 2025 total revenue: $4.80M (-1.9% YoY); foil balloons: $4.23M
• Market event: 33.7% stock price drop in October 2025 following a 1-for-10 reverse split and investor concerns after acquisition of biodegradable production assets

• Primary growth driver: foil balloon sales (80% of Q3 2025 revenue)
• Short-term headwind: reduced helium pricing depressed Q1 2025 foil balloon volumes/revenue
• Investor sentiment risk: 1-for-10 reverse split and acquisition of biodegradable production assets triggered sharp share-price decline in Oct 2025

Yunhong CTI Ltd. (CTIB) - Profitability Metrics

• Q3 2025 net loss narrowed by 32% to $811,000; EPS improved from a loss of $0.47 to a loss of $0.31.
• Gross margin in Q3 2025: 2.27% (up 3.1% year-over-year), signaling improved cost management.
• Q1 2025 net loss: $416,000, a 27.8% improvement vs. $576,000 in Q1 2024.
• Adjusted EBITDA in Q1 2025: $700,000, versus $300,000 in Q1 2024, reflecting stronger operational efficiency.
• Price-to-earnings (P/E) ratio in October 2025: -12.5 (negative earnings); historical average P/E: -11.08, indicating a deterioration relative to history.

• Improving margins and rising adjusted EBITDA point to operational gains, but persistent negative EPS and a deteriorating P/E highlight ongoing profitability risks.
• Investors should reconcile short-term margin improvements with the negative valuation multiples and monitor quarterly progress.

Yunhong CTI Ltd. (CTIB) - Debt vs. Equity Structure

• Total assets (Q3 2025): $17.25 million.
• Total liabilities (Q3 2025): $13.51 million - implying shareholders' equity of $3.74 million (Assets - Liabilities).
• Total debt (Q3 2025): $9.06 million, comprised of $5.67 million short-term and $3.39 million long-term debt.
• Debt-to-assets ratio (Q3 2025): ~78% (13.51 / 17.25 ≈ 0.78).
• Year-over-year total debt increase: 17.3% (total debt higher than prior year).
• Historical leverage: debt-to-assets ~78% in 2023 vs. ~82% in 2022 (a modest improvement).

• Implications for equity: high liabilities relative to assets leave shareholders' equity concentrated ($3.74M), and rising debt (+17.3% YoY) can compress equity cushions if asset growth lags or losses occur.
• Reverse stock split (1-for-10, Oct 2025): mechanically increases the per-share book value and market price per share but does not change aggregate equity; may influence investor perception and liquidity.
• Short-term debt concentration ($5.67M): raises near-term refinancing and liquidity risk, especially given the elevated debt-to-assets ratio.

Yunhong CTI Ltd. (CTIB) - Liquidity and Solvency

• Net cash position (Q3 2025): $0.39 million, up 7,640% YoY - large percentage gain but small absolute amount.
• Cash reserves fell to $172,000 in Q1 2025 from $220,000 at end-2024, highlighting tight near-term liquidity.
• Accounts receivable (Q3 2025): $2.69 million, +22.5% YoY - indicates higher sales but potential collection risk.
• Inventory (Q3 2025): $8.7 million, +10.5% YoY - potential overstocking and increased holding costs.
• Capital structure events: 1-for-10 reverse split in Oct 2025 - likely reduced float and may have impacted trading liquidity.
• Profitability and debt: ongoing losses and rising debt levels compound liquidity strain and solvency risk.

• Working capital pressures: AR and inventory increases can strain cash conversion; monitor days sales outstanding and days inventory outstanding.
• Low cash buffer: sub-$200k cash balances leave little runway for operating needs or unexpected expenses.
• Leverage and profitability: rising debt with weak profits heightens solvency risk and could lead to additional financing or dilution.
• Market liquidity: the 1-for-10 reverse split likely reduced tradable shares, which can amplify price volatility and reduce market liquidity.

Yunhong CTI Ltd. (CTIB) - Valuation Analysis

• P/E (Nov 2025): -26.67 - reflects negative earnings and materially worse valuation relative to historical norms.
• Historical average P/E: -15.60 - company has moved further into negative territory versus its long‑run average.
• Average P/E over last four quarters: -11.08 - November 2025 P/E represents a 140.74% change compared to this recent average.

• Interpretation: the deepening negative P/E indicates either widening net losses, lower earnings quality, or market repricing of future expectations.
• Investor considerations:
  • Reassess profit drivers and cost structure given the sustained negative multiples.
  • Compare cash position, debt levels, and near‑term cash flow to gauge runway versus valuation pressure.
  • Monitor upcoming earnings releases for signs of margin recovery or further deterioration.

Yunhong CTI Ltd. (CTIB) - Risk Factors

• Market reaction to corporate actions: the 1-for-10 reverse stock split in October 2025 coincided with a 33.7% drop in the stock price, signaling heightened volatility and investor concern over dilution and capital structure moves.
• Profitability pressures: a net loss of $811,000 in Q3 2025 and negative EPS demonstrate ongoing challenges turning operations profitable.
• High financial leverage: a debt-to-assets ratio of 78% in Q3 2025 indicates significant leverage and elevated solvency risk if revenues or margins deteriorate further.
• Liquidity strain: cash reserves decreased to $172,000 in Q1 2025, posing risks to meeting short-term obligations and funding near-term operations or capex needs.
• Commodity exposure: revenue declined in Q1 2025, attributed in part to reduced helium pricing-showing sensitivity to commodity price swings that can compress top-line and margins.
• Regulatory and market risk from product focus: the company's emphasis on biodegradable and compostable products exposes it to changing environmental standards, certification requirements, and shifting consumer/regulatory demand.

• Short-term solvency risk: with $172k cash and high leverage, unexpected capex, litigation, or working capital needs could force dilutive financing or asset sales.
• Revenue volatility: reliance on commodity-linked inputs/prices (helium) can rapidly alter margins and cash flow forecasts.
• Regulatory/compliance risk: evolving environmental regulations and certification standards for biodegradable/compostable goods could increase costs or constrain market access.
• Investor sentiment risk: the steep post-split share decline (-33.7%) underscores sensitivity to perceived governance, capital structure, and execution risks.

Yunhong CTI Ltd. (CTIB) - Growth Opportunities

• June 2024 acquisition: adds biodegradable resin compounding and conversion capacity, enabling internal production of degradable films and molded goods.
• Partnership with Yunhong Biotechnology, Inc.: co-development of compostable material formulations targeted for packaging and single-use applications.
• Expansion into balloon-inspired gift items: leverages existing conversion capabilities to enter a higher-margin, trend-driven retail segment.
• Robotic automation investments: targeted for pick-and-place, trimming, and packaging operations to increase throughput and lower labor-related operating expenses.
• Corporate rebrand to Yunhong Green CTI Ltd. and ticker change to 'YHGJ': signaling strategic pivot to sustainability to attract ESG-focused capital flows.

• Global biodegradable packaging market size: ~USD 8-10 billion in 2023 with an expected CAGR of ~12-14% through 2028 - implying a materially larger addressable market by late-decade for CTIB products.
• Compostable polymers adoption: regulatory tailwinds (single-use plastic bans and extended producer responsibility) in key markets drive procurement commitments from retailers and foodservice chains.
• Robotics ROI expectations: typical automation projects in light manufacturing target 12-36 month payback via labor cost reductions of 20-40% on automated lines and uptime improvement of 5-10%.
• Novel product lines (balloon-inspired gifts): short product development cycles with potential gross margin expansion vs. commodity films due to branding and retail pricing flexibility.

• Throughput from acquired biodegradable asset lines - measured as tons/month and yield rates after ramp-up.
• Conversion of R&D formulations into certificated compostable products (e.g., compostability certification timelines and cost per ton).
• Retail and B2B channel wins for balloon-inspired items - SKU velocity and repeat order rates.
• Realized automation savings vs. projected capital expenditures and timeline to achieve projected payback.
• Investor reception following the planned name/ticker change and any associated ESG reporting enhancements.